First Time Loading...

Northeast Pharmaceutical Group Co Ltd
SZSE:000597

Watchlist Manager
Northeast Pharmaceutical Group Co Ltd Logo
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Watchlist
Price: 4.77 CNY 1.27% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. [ Read More ]

The intrinsic value of one Northeast Pharmaceutical Group Co Ltd stock under the Base Case scenario is 6.46 CNY. Compared to the current market price of 4.77 CNY, Northeast Pharmaceutical Group Co Ltd is Undervalued by 26%.

Key Points:
Intrinsic Value
Base Case
6.46 CNY
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Northeast Pharmaceutical Group Co Ltd

Backtest Northeast Pharmaceutical Group Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Northeast Pharmaceutical Group Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
Northeast Pharmaceutical Group Co Ltd

Current Assets 8.3B
Cash & Short-Term Investments 2B
Receivables 3B
Other Current Assets 3.3B
Non-Current Assets 5.7B
PP&E 4.7B
Intangibles 861.3m
Other Non-Current Assets 118.4m
Current Liabilities 8.6B
Accounts Payable 1.8B
Accrued Liabilities 47.8m
Short-Term Debt 5.1B
Other Current Liabilities 1.7B
Non-Current Liabilities 727.6m
Long-Term Debt 170.9m
Other Non-Current Liabilities 556.7m
Efficiency

Earnings Waterfall
Northeast Pharmaceutical Group Co Ltd

Revenue
8.6B CNY
Cost of Revenue
-5.2B CNY
Gross Profit
3.4B CNY
Operating Expenses
-3.1B CNY
Operating Income
318.2m CNY
Other Expenses
123.6m CNY
Net Income
441.8m CNY

Free Cash Flow Analysis
Northeast Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Northeast Pharmaceutical Group Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
ROE is Increasing
Positive 3-Years Revenue Growth
49/100
Profitability
Score

Northeast Pharmaceutical Group Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Northeast Pharmaceutical Group Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average D/E
Positive Net Debt
45/100
Solvency
Score

Northeast Pharmaceutical Group Co Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Northeast Pharmaceutical Group Co Ltd

There are no price targets for Northeast Pharmaceutical Group Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Northeast Pharmaceutical Group Co Ltd

1M 1M
+2%
6M 6M
-9%
1Y 1Y
-16%
3Y 3Y
+6%
5Y 5Y
-18%
10Y 10Y
+41%
Annual Price Range
4.77
52w Low
3.9
52w High
5.83
Price Metrics
Average Annual Return 5.32%
Standard Deviation of Annual Returns 21.36%
Max Drawdown -86%
Shares Statistics
Market Capitalization 6.8B CNY
Shares Outstanding 1 445 538 524
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Northeast Pharmaceutical Group Co Ltd Logo
Northeast Pharmaceutical Group Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

6.8B CNY

Dividend Yield

2.11%

Description

Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. The company is headquartered in Shenyang, Liaoning and currently employs 7,102 full-time employees. The firm's main products include bulk pharmaceutical chemicals (BPCs), formulations and bio-diagnostic reagents. The firm is also involved in the pharmaceutical engineering business through its subsidiaries. The firm mainly conducts its business in domestic market and overseas markets.

Contact

LIAONING
Shenyang
No. 8, Kunminghu Street, Shenyang Economic and Technological Development Zone
+862425806963
http://www.nepharm.com.cn

IPO

1996-05-23

Employees

7 102

Officers

GM & Director
Mr. Zhou Kai
Financial Director
Mr. Jialun Song
Deputy General Manager
Ms. Wei Zheng

See Also

Discover More
What is the Intrinsic Value of one Northeast Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Northeast Pharmaceutical Group Co Ltd stock under the Base Case scenario is 6.46 CNY.

Is Northeast Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4.77 CNY, Northeast Pharmaceutical Group Co Ltd is Undervalued by 26%.